查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2073723

精準醫療人工智慧市場：按組件、治療應用、技術、最終用途、國家和地區分類－全球產業分析、市場規模及佔有率、未來預測（2026-2033）

AI in Precision Medicine Market, By Component, By Therapeutic Application, By Technology, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 420 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年，精準醫療人工智慧市場價值10.563億美元，預計從2026年到2033年將以29.7%的複合年成長率成長。

在精準醫療中，人工智慧（AI）指的是利用智慧數據處理系統和預測分析技術來分析大量與患者相關的數據，包括基因組數據、病歷、診斷結果和生活方式等。人工智慧能夠幫助醫療專業人員從複雜的資料集中識別有意義的關聯，並提供個人化的疾病預防、診斷和治療方案。這有助於提高預測患者預後、及早發現健康風險以及最佳化治療策略的能力。

人工智慧精準醫療市場動態

多體學數據與先進分析方法的整合正在不斷發展，個人化醫療的趨勢預計將推動市場需求。

精準醫療領域人工智慧市場的成長正受到醫療數據快速成長以及將這些資訊轉化為可操作的臨床見解的需求日益成長的推動。醫院、研究機構和診斷檢查室正從基因測序、蛋白質體學分析、電子健康記錄、醫學影像系統和連線健診設備產生大量資料。人工智慧技術在組織、分析和解讀這些複雜的資料集方面發揮著至關重要的作用，幫助醫生做出更準確、更個人化的治療決策。近期的進展包括人工智慧驅動的基因組分析平台、大規模醫療基礎設施模型以及能夠更準確地識別疾病風險和治療反應的預測演算法。產業報告顯示，全球醫療數據產生量正以每年超過30%的速度成長，對先進的分析工具產生了強勁的需求。此外，醫療機構正擴大採用整合資料生態系統，將臨床、分子和真實世界的病患資訊整合到一個統一的框架中。這項進展正在提高疾病預測的準確性，促進早期療育，並實現更個人化的護理策略。隨著醫療數據的數量和複雜性不斷增加，人工智慧正成為下一代精準醫療舉措的重要組成部分。

推動精準醫療人工智慧市場發展的另一個關鍵因素是，人們日益關注個人化治療方案，以及藥物研發全生命週期中對效率提升的需求。製藥和生物技術公司正擴大利用人工智慧來發現新的治療標靶、改進臨床試驗中的患者選擇，並更準確地預測治療結果。這些功能有助於簡化研究活動、降低研發成本，並提高產品商業化的成功率。新興趨勢包括人工智慧驅動的生物標記識別、先進的患者細分技術，以及能夠根據患者的基因和臨床特徵為其匹配最合適療法的智慧平台。精準腫瘤解決方案的日益普及、對罕見疾病和遺傳疾病的關注度不斷提高，以及對慢性病個人化管理需求的不斷成長，都在進一步加速市場成長。

人工智慧精準醫療市場：細分市場分析

全球精準醫療人工智慧市場按組件、治療應用、技術、最終用途和地區進行細分。

根據其組成部分，市場可分為三大類：硬體、軟體和服務。由於人工智慧解決方案在基因組分析、預測性醫療分析、臨床決策支援和患者細分等領域的應用日益廣泛，軟體領域正推動硬體領域的成長。相較之下，硬體領域則包括高效能運算基礎設施、先進的資料儲存系統以及專用人工智慧處理單元，這些都能夠有效率地分析龐大且複雜的醫療資料集。

根據治療應用領域，精準醫療人工智慧市場可分為六大類：腫瘤學、神經科、循環系統、感染疾病、罕見疾病及其他。腫瘤學在精準醫療人工智慧市場中佔據最大佔有率，這主要得益於人工智慧技術在癌症早期檢測、腫瘤譜分析、生物標記發現、治療反應預測和個人化治療方案選擇等方面的廣泛應用。人工智慧工具能夠幫助臨床醫生分析複雜的基因組和分子數據，進而製定更精準、更具針對性的癌症治療策略。全球癌症發生率的不斷攀升，以及對精準腫瘤學研究投入的持續成長，正推動著該領域的持續發展。

人工智慧精準醫療市場—區域分析

北美在精準醫療人工智慧市場處於領先地位，這得益於其先進的醫療基礎設施、強大的生物技術生態系統以及數位健康技術的廣泛應用。該地區受益於大規模基因組研究舉措、電子健康記錄的普及以及在醫療保健應用領域對人工智慧的大量投資。製藥公司、研究機構和醫療服務提供者正日益將人工智慧融入藥物研發、生物標記識別和個人化治療方案製定中。

隨著對醫療數位化、基因組醫學計畫和人工智慧驅動的臨床研究投入的不斷增加，歐洲正成為人工智慧精準醫療的領先市場。各國政府和醫療機構都在積極支持個人化醫療和數據驅動的疾病管理。人工智慧工具在臨床決策支援、人群健康分析和精準腫瘤學領域的日益普及，正在推動市場成長。例如，「百萬基因組舉措」旨在促進參與的歐洲國家之間安全共享基因組和健康相關數據。這項合作正在加速基因組研究，加深對疾病的理解，並加強全部區域人工智慧精準醫療解決方案的發展。

目錄

第1章：精準醫療人工智慧市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：人工智慧精準醫療的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：人工智慧精準醫療市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景：概覽
  • 管理體制分析

第5章：人工智慧在精準醫療領域的市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：人工智慧精準醫療市場趨勢

  • 人工智慧精準醫療市場佔有率分析（2025 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：精準醫療人工智慧市場：按組件分類

  • 概述
    • 基於細分市場的市場佔有率分析：按組件
    • 硬體
    • 軟體
    • 服務

第8章：人工智慧精準醫療市場：依治療應用分類

  • 概述
    • 基於細分市場的市場佔有率分析：按治療應用分類
    • 瘤
    • 神經科
    • 循環系統
    • 感染疾病
    • 罕見疾病
    • 其他

第9章：精準醫療人工智慧市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 機器學習（ML）
    • 自然語言處理（NLP）
    • 電腦視覺
    • 其他

第10章：精準醫療人工智慧市場：依最終用途分類

  • 概述
    • 基於細分市場的市佔率分析：依最終用途
    • 藥物發現與開發
    • 基因組分析
    • 詳細診斷
    • 臨床決策支持
    • 預測分析
    • 其他

第11章：精準醫療人工智慧市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第12章：主要供應商分析：人工智慧精準醫療產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Tempus AI
    • Illumina
    • NVIDIA
    • IBM
    • Microsoft
    • Google
    • SOPHiA GENETICS
    • IQVIA
    • Guardant Health
    • Astrazeneca
    • Sanofi
    • Roche
    • Thermo Fisher Scientific
    • Qiagen
    • Bio-Rad Laboratories
    • Others

第13章：使用 AnalystView 進行綜合分析

簡介目錄
Product Code: ANV6769

AI in Precision Medicine Market size was valued at USD 1,056.3 Million in 2025, expanding to a CAGR of 29.7% from 2026 to 2033.

In precision medicine, AI means using smart data-processing systems and predictive analytics to analyze large amounts of patient-related data, including genomic data, clinical histories, diagnostic findings, and lifestyle characteristics. AI helps healthcare professionals to identify meaningful relationships in complex data sets and provide personalized approaches for disease prevention, diagnosis, and treatment. It improves the capability to predict patient outcomes, to identify health risks early and to optimize treatment decisions.

AI in Precision Medicine Market- Market Dynamics

Increasing integration of multi-omics data and advanced analytics and trend of personalized therapies are expected to propel market demand

AI in precision medicine market growth is accelerated by the rapid expansion of healthcare data and the increasing need to transform this information into actionable clinical insights. Hospitals, research institutions, and diagnostic laboratories generate enormous volumes of data from genomic sequencing, proteomic analysis, electronic health records, medical imaging systems, and connected health devices. AI technologies are playing a crucial role in organizing, analyzing, and interpreting these complex datasets, helping physicians make more precise and individualized treatment decisions. Recent advancements include AI-enabled genomic analysis platforms, large-scale healthcare foundation models and predictive algorithms proficient of identifying disease risks and therapy responses with more accuracy. According to industry reports, global healthcare data generation is growing by more than 30% per year, creating a solid demand for advanced analytical tools. In addition, healthcare organizations are increasingly implementing integrated data ecosystems that combine clinical, molecular, and real-world patient information into a unified framework. This development is improving disease prediction, supporting earlier interventions, and enabling more personalized care strategies. As the volume and complexity of healthcare data continue to rise, AI is becoming an indispensable component of next-generation precision medicine initiatives.

Another significant factor driving the AI in precision medicine market is the growing emphasis on personalized treatment approaches and the need to enhance efficiency across the drug development lifecycle. Pharmaceutical and biotechnology companies are increasingly leveraging AI to uncover new therapeutic targets, improve patient selection for clinical trials, and forecast treatment outcomes more accurately. These abilities help streamline research activities, lower development money, and increase the chances of successful product commercialization. Emerging developments include AI-powered biomarker identification, advanced patient segmentation techniques, and intelligent platforms that connect individuals with therapies best suitable for their genetic and clinical profiles. The rising adoption of precision oncology solutions, increasing focus on rare and genetic disorders and demand for customized management of chronic diseases are further accelerating market growth.

AI in Precision Medicine Market- Segmentation Analysis:

The Global AI in Precision Medicine Market is segmented on the basis of Component, Therapeutic Application, Technology, End-Use, and Region.

The market is divided into three categories based on Component: Hardware, software, and services. The software segment is leading the component segment due to the increasing adoption of AI-based solutions for genomic interpretation, predictive healthcare analytics, clinical decision support, and patient segmentation. In contrast, the hardware segment includes high-performance computing infrastructure, advanced data storage systems, and specialized AI processing units, which facilitate the efficient analysis of large-scale and complex medical datasets.

The market is divided into six categories based on Therapeutic Application: oncology, neurology, cardiology, infectious diseases, rare diseases, and others. Oncology holds the foremost share of the AI in precision medicine market due to the extensive adoption of AI technologies for early cancer detection, tumor profiling, biomarker discovery, treatment response prediction, and personalized therapy selection. AI-driven tools help clinicians analyze complex genomic and molecular data, enabling more accurate and targeted cancer treatment strategies. The increasing prevalence of cancer worldwide, coupled with rising investments in precision oncology research, continues to strengthen this segment's growth.

AI in Precision Medicine Market- Geographical Insights

North America leads the AI in precision medicine market, supported by its advanced healthcare infrastructure, strong biotechnology ecosystem, and extensive adoption of digital health technologies. The region benefits from large-scale genomic research initiatives, widespread use of electronic health records, and significant investments in artificial intelligence across healthcare applications. Pharmaceutical companies, research institutions, and healthcare providers are increasingly integrating AI into drug discovery, biomarker identification, and personalized treatment planning.

The increasing investments in healthcare digitalization, genomic medicine programs and AI-based clinical research make Europe a key market in AI precision medicine. Governments and healthcare organizations are supporting initiatives around personalized healthcare and data-driven disease management. The progressive adoption of AI tools for clinical decision support, population health analysis and precision oncology are aiding the growth of the market. One such initiative is 1+ Million Genomes Initiative, which promotes secure access to genomic and health-related data across participating European countries. This collaborative effort is accelerating genomic research, improving disease understanding, and strengthening the development of AI-powered precision medicine solutions throughout the region.

United States AI in Precision Medicine Market- Key Insights

The United States holds the largest share of the AI in precision medicine market due to its strong healthcare and biotechnology sectors, developed digital infrastructure and substantial investments in artificial intelligence research. The U.S. is home to various pharmaceutical companies, biotechnology firms, AI startups, and leading academic medical centers that are actively developing precision medicine solutions. The growing adoption of genomic sequencing, electronic health records, and AI-powered clinical decision support systems is accelerating market growth. Furthermore, rising investments in AI-driven drug discovery, biomarker identification, and predictive analytics are enabling faster and more precise treatment development. The availability of extensive healthcare datasets, favorable research funding, strong collaboration between technology and life sciences companies is also boosting U.S. position in the global market.

AI in Precision Medicine Market- Competitive Landscape:

The AI in Precision Medicine market is moderately competitive in nature. Market participants are focusing on integrating artificial intelligence with genomics, clinical data analytics, molecular diagnostics and drug discovery platforms to deliver more personalized healthcare solutions. A key trend shaping the competitive landscape is the development of end-to-end precision medicine ecosystems that combine patient data management, biomarker identification, predictive analytics and treatment optimization within a single platform.

Moreover, companies are progressively investing in advanced machine learning models, foundation AI models for healthcare, and multimodal analytics platforms capable of processing genomic, imaging, and clinical datasets simultaneously. Mergers, acquisitions, and technology partnerships are also helping organizations strengthen their product portfolios and expand their presence across global markets.

Recent Developments:

In February 2025, Tempus AI completed acquisition of Ambry Genetics, significantly expanding its precision medicine and molecular diagnostics portfolio. Through this transaction, the company gained access to a broader genomic database and advanced genetic testing capabilities, strengthening its AI-powered platform for disease detection.

In 2025, Illumina entered into a strategic collaboration with Tempus AI to integrate advanced genomic sequencing capabilities with AI-powered data analytics. The partnership aims to enhance molecular profiling, improve the interpretation of complex genomic data, and support the broader adoption of precision medicine.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI IN PRECISION MEDICINE MARKET KEY PLAYERS

  • Tempus AI
  • Illumina
  • NVIDIA
  • IBM
  • Microsoft
  • Google
  • SOPHiA GENETICS
  • IQVIA
  • Guardant Health
  • Astrazeneca
  • Sanofi
  • Roche
  • Thermo Fisher Scientific
  • Qiagen
  • Bio-Rad Laboratories
  • Others

GLOBAL AI IN PRECISION MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033

  • Hardware
  • Software
  • Services

GLOBAL AI IN PRECISION MEDICINE MARKET, BY THERAPEUTIC APPLICATION- MARKET ANALYSIS, 2020-2033

  • Oncology
  • Neurology
  • Cardiology
  • Infectious diseases
  • Rare diseases
  • Others

GLOBAL AI IN PRECISION MEDICINE MARKET, BY TECNOLOGY- MARKET ANALYSIS, 2020-2033

  • Machine Learning (ML)
  • Natural Language Processing (NLP)
  • Computer Vision
  • Others

GLOBAL AI IN PRECISION MEDICINE MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

  • Drug Discovery & Development
  • Genomic Analysis
  • Precision Diagnostics
  • Clinical Decision Support
  • Predictive Analytics
  • Others

GLOBAL AI IN PRECISION MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI in Precision Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI in Precision Medicine Market Snippet by Component
    • 2.1.2. AI in Precision Medicine Market Snippet by Therapeutic Application
    • 2.1.3. AI in Precision Medicine Market Snippet by Technology
    • 2.1.4. AI in Precision Medicine Market Snippet by End-Use
    • 2.1.5. AI in Precision Medicine Market Snippet by Country
    • 2.1.6. AI in Precision Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. AI in Precision Medicine Key Market Trends

  • 3.1. AI in Precision Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI in Precision Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI in Precision Medicine Market Opportunities
  • 3.4. AI in Precision Medicine Market Future Trends

4. AI in Precision Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI in Precision Medicine Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. AI in Precision Medicine Market Landscape

  • 6.1. AI in Precision Medicine Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI in Precision Medicine Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Hardware
    • 7.1.3. Software
    • 7.1.4. Services

8. AI in Precision Medicine Market - By Therapeutic Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Application, 2025 & 2033 (%)
    • 8.1.2. Oncology
    • 8.1.3. Neurology
    • 8.1.4. Cardiology
    • 8.1.5. Infectious diseases
    • 8.1.6. Rare diseases
    • 8.1.7. Others

9. AI in Precision Medicine Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 9.1.2. Machine Learning (ML)
    • 9.1.3. Natural Language Processing (NLP)
    • 9.1.4. Computer Vision
    • 9.1.5. Others

10. AI in Precision Medicine Market - By End-Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
    • 10.1.2. Drug Discovery & Development
    • 10.1.3. Genomic Analysis
    • 10.1.4. Precision Diagnostics
    • 10.1.5. Clinical Decision Support
    • 10.1.6. Predictive Analytics
    • 10.1.7. Others

11. AI in Precision Medicine Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. AI in Precision Medicine Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. AI in Precision Medicine Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. AI in Precision Medicine Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. AI in Precision Medicine Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. AI in Precision Medicine Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- AI in Precision Medicine Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Tempus AI
    • 12.2.2. Illumina
    • 12.2.3. NVIDIA
    • 12.2.4. IBM
    • 12.2.5. Microsoft
    • 12.2.6. Google
    • 12.2.7. SOPHiA GENETICS
    • 12.2.8. IQVIA
    • 12.2.9. Guardant Health
    • 12.2.10. Astrazeneca
    • 12.2.11. Sanofi
    • 12.2.12. Roche
    • 12.2.13. Thermo Fisher Scientific
    • 12.2.14. Qiagen
    • 12.2.15. Bio-Rad Laboratories
    • 12.2.16. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us